Search research articles
Contact Us
Filters
Showing results (81-90 of 220) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2016
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung
David R Spigel, Martin J Edelman, Kenneth O'Byrne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial
David R Spigel, Peter M Townley, David M Waterhouse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2010
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
ESMO Open
|
August 30, 2017
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort
Howard A Burris, Suzanne Bakewell, Johanna C Bendell, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2018
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium
David R Spigel, John D Hainsworth, Dianna L Shipley, et al.
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2011
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors
Suzanne F Jones, Johanna C Bendell, Jeffrey R Infante, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 9, 2018
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370)
David R Spigel, Craig Reynolds, David Waterhouse, et al.
Cancer Chemotherapy and Pharmacology
|
June 1, 2011
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Targeted Oncology
|
November 19, 2024
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors
Manish R Patel, Gerald S Falchook, Judy S Wang, et al.
The Oncologist
|
October 27, 2005
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial
F Anthony Greco, Dana S Thompson, Lisa H Morrissey, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 220) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2016
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung
David R Spigel, Martin J Edelman, Kenneth O'Byrne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2011
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial
David R Spigel, Peter M Townley, David M Waterhouse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2010
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
ESMO Open
|
August 30, 2017
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort
Howard A Burris, Suzanne Bakewell, Johanna C Bendell, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2018
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium
David R Spigel, John D Hainsworth, Dianna L Shipley, et al.
Clinical Advances in Hematology & Oncology : H&O
|
April 9, 2011
A phase I study of panobinostat in combination with gemcitabine in the treatment of solid tumors
Suzanne F Jones, Johanna C Bendell, Jeffrey R Infante, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 9, 2018
Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370)
David R Spigel, Craig Reynolds, David Waterhouse, et al.
Cancer Chemotherapy and Pharmacology
|
June 1, 2011
A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine
Jeffrey R Infante, Suzanne F Jones, Johanna C Bendell, et al.
Targeted Oncology
|
November 19, 2024
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors
Manish R Patel, Gerald S Falchook, Judy S Wang, et al.
The Oncologist
|
October 27, 2005
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial
F Anthony Greco, Dana S Thompson, Lisa H Morrissey, et al.
Page
of 22